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Abstract
Background:
Globally, more than 5.7% of the population reside above 1,500 m of elevation. It has been hypothesized that acute
short-term hypoxia exposure could increase the risk of developing a stroke. Studies assessing the effect of altitude
on stroke have provided con icting results, some analysis suggest that long-term chronic exposure could be
associated with reduced mortality and lower stroke incidence rates.
Methods:
An ecological analysis of all stroke hospital admissions, mortality rates and disability adjusted life years in
Ecuador was performed from 2001-2017. The cases and population at risk were categorized in low (<1,500 m),
moderate (1,500-2,500 m), high (2,500-3,500 m) and very high altitude (3,500-5,500 m) according to place of
residence. The derived crude and direct standardized age-sex adjusted mortality and hospital admission rates were
calculated.
Results:
A total of 38,201 deaths and 75,893 stroke-related hospital admissions were reported. High-altitude populations
(HAP) had lower stroke mortality in men (RR: 0.91 [0.88 - 0.95]) and women (RR: 0.83 [0.79 - 0.86]). In addition,
HAP had a signi cant lower risk of getting admitted to the hospital when compared with the low altitude group in
men (RR: 0.55 [CI95% 0.54 - 0.56]) and women (RR: 0.65 [CI95% [0.64 - 0.66]).
Conclusions:
This is the rst epidemiological study that aims to elucidate the association between stroke and altitude using four
different elevation ranges. Our ndings suggest that living at higher elevations offers a reduction or the risk of
dying due to stroke as well as a reduction in the probability of being admitted to the hospital. Nevertheless, this
protective factor has the stronger effect between 2,000 m to 3,500 m.

Background
Cerebrovascular disease or stroke is the second leading cause of death worldwide; affecting more than 16 million
people each year[1]. Around 1 in 6 men and 1 in 5 women will have a stroke in their lifetime, In 2016, the global
lifetime risk of stroke from the age of 25 years onward was approximately 25% among both men and women[2].
Stroke is the third leading cause of disability worldwide and affects people of all ages, though the causes of stroke
a younger age are very different from those at older ages[3–6]. The risk of developing stroke increases with high
blood pressure, atrial brillation, cigarette smoking, hyperlipidemia and diabetes mellitus[1]. Other modi able
factors are obesity, chronic kidney disease, excessive alcohol use, cocaine consumption, sedentarism,
psychological stress and depression[7–9]. The list of non-traditional factors linked to stroke includes some
environmental conditions such as high-altitude exposure. Hypobaric hypoxia due to living in mountainous regions
may play a role in stroke incidence and mortality; nonetheless, this environmental factor has been poorly
investigated. [10–14].
Globally, at least 5.7% of the population live above 1,500 meters, with millions of people chronically exposed to
high altitude. The association between high-altitude exposure and stroke is still unknown and the very few
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investigations available are still inconclusive[11, 12, 15]. It has been di cult to de ne at which elevation the effects
of high-altitude become more severe and where the threshold is located in terms of mild or severe hypoxia[16]. The
International Society of Mountain Medicine de nes low altitude everything located below 1,500 m, moderate or
intermediate altitude between 1,500 to 2,500 m, high-altitude from 2,500 to 3,500 m, the very high-altitude from
3,500 m to 5,800, more than 5,800 extreme high-altitudes and above the 8,000 m is considered the death zone [17].
Anecdotal evidence suggest that acute exposure to high-altitude (>2,500 m) might increase the risk of thrombosis
secondary to short-term hypoxia, which has been associated with the development of ischemic stroke[18–20].
Most of these studies found a signi cant association between living in high-altitude and having a higher risk of
stroke, especially among younger populations (< 45 years of age) [11, 12, 21, 22]. Paradoxical results were
published by Faeh, et.al in 2009 [22]. They found a decreased risk of cardiovascular diseases (CVD) and stroke
related mortality among those living in high altitude locations in Switzerland [22]. This study reported a 12%
decreased risk of cardiovascular diseases and stroke related mortality per 1,000 m of elevation according to
mortality data from the year 1990 to 2000. The dataset included sociodemographic information, place of birth and
place of residence as well as the median elevation of each city, ranging from 259 to 1,960 m [22]. Although this
offers a new perspective of the potential protective effect of living at higher altitudes, the elevation range did not
surpass 2,000 meters, making it di cult to extrapolate the results to other mountainous regions of the world. There
are regions of the world with millions of people living above 2,500 m including the South American Andes, the
Indochinese Himalayas and the Ethiopian Plateaus[23].
To further explore the relationship between high altitude and stroke, we conducted a nationwide ecological study in
Ecuador with data from 2001 to 2017, including more than 100,000 stroke patients living at different elevations,
ranging from 0 m at sea level to 4,300 meters within the Ecuadorian highlands.

Methodology

Study design
This is an ecological analysis of the geographical distribution of stroke using hospital admissions as a proxy for
incidence and stroke mortality in Ecuador from 2001 to 2017. The analysis included all the stroke cases and
fatalities reported in every city (cantons) of Ecuador as the unit of analysis with a yearly resolution. Stroke cases
included all the hospital admissions and deaths according to the patient’s place of residence reported to the
National Institute of Census and Statistics (INEC) including the following ICD-10 diagnoses: I60 subarachnoid
haemorrhage (SAH), I61 intracerebral haemorrhage (ICH), I63 ischaemic stroke (IS) and I64 as not speci ed stroke.

Sample and setting
A country-wide comparison of the total number of strokes from the 24 provinces and the 221 cantons in Ecuador
was performed from 2001-2017. Ecuador with an area of more than 283,000 Km2 is the smallest country in the
Andean mountainous region in South America. The country is divided into 4 geographical regions, the coast, the
highlands, the Amazon region and the Galapagos Islands. The political division encloses 24 provinces, 10 from the
highlands, 7 from the coast, 6 from the Amazon region and 1 from the insular region of Galapagos. Every province
has several political divisions called cantons and they are comparable to cities elsewhere.
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Population
According to the 2017 National Institute of Census and Statistics (INEC) data projections, Ecuador has a
population of 17,082,730, 51% women and 49% men. In terms of ethnicity, most of people are Mestizo (79.3%),
followed by Afro-Ecuadorians (7.2%), indigenous (7.1%), white or Caucasians descendants (6.1%) and other groups
(0.4%)[24].

Exposure
The association between altitude exposure and stroke incidence and mortality was analysed. The classi cation of
low altitude < 2,500 m and high-altitude >2,500 m was used as a cut-off point for elevation exposure, while the
classi cation offered by the International Society of Mountain Medicine (low altitude (<1,500 m), moderate altitude
(1,500 to 2,500 m), high-altitude (2,500 to 3,500 m) and very high-altitude (3,500 to 5,500 m) was used to assess
prevalence odds ratios by different elevations.

Outcome
Stroke age-sex and altitude adjusted incidence and mortality rates were calculated using the total number of stroke
hospital admissions and all the stroke-related deaths in Ecuador.

Data source
Data was retrieved from the National Institute of Census and Statistics (INEC) using the general hospital
admission and the mortality databases for the last 17 years of available data on discharges and death certi cates
according to the patient’s place of residence within the public and private health system in Ecuador. The databases
included the latest International Classi cation of Diseases 10th Revision (ICD-10) coding system and the
information concerning stroke was retrieved from the INEC public domain at
https://www.ecuadorencifras.gob.ec/.

Inclusion criteria
Using the International Classi cation of Diseases 10th Revision (ICD-10) the following subtypes of stroke cases
and deaths were included: I60 subarachnoid haemorrhage (SAH), I61 intracerebral haemorrhage (ICH), I63
ischaemic stroke, I64 Stroke not speci ed and the combination of all of them in a new variable called “all strokes”.

Exclusion criteria
Patient without an ICD-10 diagnosis of stroke were not included[25]. The following ICD-10 codes including
transient ischemic attack (TIA) were excluded: I65 Occlusion and stenosis of precerebral arteries, not resulting in
cerebral infarction, I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction, I67 Other
cerebrovascular diseases, I68 Cerebrovascular disorders in diseases classi ed elsewhere and I69 Sequelae of
cerebrovascular disease.
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Statistical analysis
Incidence and mortality crude and age-sex adjusted rates were calculated using the population at risk for every
altitude location. The 2010 Ecuadorian census data was used as the standard population for the direct
standardization[26]. Measurements of frequency (counts, absolute and relative percentages), central tendency
(mean and median) and dispersion (range and standard deviation) as well as absolute differences were performed
for age, sex and the canton’s elevation.
To reduce the impact of age-sex population distribution’s differences at different altitudes, a direct standardization
method was applied to calculate incidence and mortality. A Poisson regression was used to nd the altitude effect
on incidence / mortality after adjusting for age and sex. For association, we obtained OR for the total number of
expected cases by the population at risk in all the groups to obtain the likelihood of death due to stroke hospital
admissions. Poisson regression models were used to quantify the association between sex, altitude, age and the
risk of stroke. Relative risks were obtained from the exponents of the coe cients of the corresponding models.
The analysis if the data was performed using the SPSS statistics software for Mac (IBM Corp. 2014, version 24.0.
Armonk, NY, USA) and the Poisson analysis was done in R version 3.6.2. Figures and graphs were performed in
Prism 8 GraphPad Software version 8.2.0 (2365 Northside Dr. Suite 560, San Diego, CA 92108). The basic
cartography maps were generated using QGIS Development Team 2.8 (Creative Commons Attribution-ShareAlike
3.0 licence CC BY-SA).

Ethical consideration
This secondary data analysis of publicly available, anonymized data received ethical approval from the University
of Southampton with the Faculty of Medicine Ethics Committee ERGO 51422.R3 number.

Results
From 2001 to 2017 a total of 38,201 deaths and 75,893 hospital admissions due to stroke (I60, I61, I62 and I64)
were reported to INEC. The sex distribution for the deceased was 19,163 deaths for men and 19,038 for women. In
terms of hospital admissions, men accounted for 52% (n= 39,569) and women 48% (n= 36,324) of hospital stroke
admissions. Sex was not a risk factor for stroke when female is used as a reference (OR: 1.01 [0.99-1.028], p value:
0.434).
We found that patients who reside at high altitudes develop stroke at a later age than the low altitude dwellers
(Table 1).
Table 1 Age difference between altitude categories
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Mortality
Media

Hospital Admission
CI 95%

Men

Median

CI 95%

Women

Median

CI 95%

Men

Median

CI 95%

Women

<2,500 m

72

[72 -74]

76

[76 -77]

66

[66 - 67]

68

[68 -69]

>2,500 m

76

[76 -78]

79

[78 -81]

69

[69 -70]

71

[71 -72]

Low Altitude

71

[71-72}

75

[75 -76]

66

[66-67]

68

[67-68]

Moderate Altitude

77

[76 -79]

78

[77 -81]

68

[67 -70]

73

[73 -74]

High-altitude

75

]74 -79]

79

[78 -81]

69

{69 -70]

71

[71 -72]

Very High-altitude

78

[74-82]

77

[73 -83]

67

[65-71]

71

[69 - 74]

Pooled Age and Sex-adjusted stroke death rates (2011-2017)
In terms of Mortality, when the age-sex adjusted rates were applied to the low (<2,500 m) and high (>2,500 m)
altitude population, the results demonstrate that the mortality rate is greater for the low altitude group in men (16.5
/ 100,000 [CI95% 11.5 - 21.4]) and women (16.2 / 100,000 [CI95% 11.7 - 20.8]) versus 10.6 / 100,000 [CI95% 6.9 14.3]) and women (12.3 / 100,000 [CI95% 8.45 - 16.9]) (Figure 1).
Age and Sex-adjusted stroke mortality and stroke admission rates by age groups
Stroke mortality rates are signi cantly lower among younger population (< 40 years of age) in both groups (low vs
high), nevertheless, mortality increases from 40 to 50 years of age in more than 200% for both groups.
Stroke hospital admission rates are also higher among lowlanders and increases signi cantly after the 50’s (Figure
2).

Difference in Mortality and hospital admission rates in age and sex-strati ed populations
Age-sex adjusted rates at different elevations demonstrated that mortality and admission hospital rates per
100,000 people are greater for the low and moderate altitude groups in men and women when compared to the
high and very high- altitude groups (Table 2).
Table 2 Age-Sex Adjusted Mortality and Hospital Admission Stroke rates in Ecuador and the absolute differences in
rates when compared to the reference elevation (Low altitude).
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Deaths

Hospital Admission

(n)

Age-Adjusted
Rates

Diff

(n)

Age-Adjusted
Rates

Diff

Low Altitude (<1,500)

11,241

57.9

Ref

25,003

305.4

Ref

Moderate Altitude (1,5002,500)

1,887

55.6

-2.3

4,412

255.9

-49.4

High-altitude (2,500-3,500)

5,674

44.4

-13.5

9,921

196.8

-108.6

Very High-altitude (3,5005,500)

361

53.1

-4.8

233

170.0

-135.4

Total

19,163

N/A

-7

39,569

N/A

-98

Low Altitude (<2,500)

13,344

56.3

Ref

29,652

291.6

Ref

High-altitude (>2,500)

5,819

47.4

-8.9

9,917

204.3

-87.3

Total

19,163

N/A

-8.9

39,569

N/A

-87.3

Low Altitude (<1,500)

9,770

53

Ref

20,371

251.6

Ref

Moderate Altitude (1,5002,500)

2,222

57.2

4.2

4,657

259.2

7.6

High-altitude (2,500-3,500)

6,690

54.8

1.8

11,096

200.7

-50.9

Very High-altitude (3,5005,500)

356

44.1

-8.9

200

164.5

-87.1

Total

19,038

N/A

-1

36,324

N/A

-43.5

Low Altitude (<2,500)

12,183

52.6

Ref

25,312

246.5

Ref

High-altitude (>2,500)

6,855

56.9

4.3

11,012

208.5

-38.0

Total

19,038

N/A

4

36,324

N/A

-37.9

Man

Women

Stroke mortality and hospital admission relative risk at low (<2,500 m) and
high (>2,500 m) altitude
In the last 17 years of available data, we can observe that hospital admission is less likely to occur in the
highlands for men RR: 0.69 CI95% [0.68 - 0.71] and women RR: 0.83 CI95% [0.83 - 0.86], while at 2,500 m of
elevation and above, mortality risk was only reduced among men RR: 0.84 CI95% [0.81 - 0.87] but no among
women 1.08 CI95% [1.05 - 1.12].

Stroke mortality and hospital admission relative risk at four different elevation ranges
Populations from very high-altitudes are less likely to die due to stroke in both, men (OR: 0.91 [0.88 - 0.95]) and
women (OR: 0.83 [0.79 - 0.86]). Getting admitted to the hospital is also less likely to occur in the high-altitude
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group (OR: 0.55 CI95% [0.54 - 0.56] when compared with the low altitude group OR: 0.65 CI95% [0.64 - 0.66])
(Figure 3).

Burden of disease analysis
In terms of years of life lost prematurely (YLL), stroke predominantly caused mortality among older adults,
especially men. From 2001 at least 109,759 years of life were lost prematurely due to stroke, 57, 521 (52%) among
men and 52, 238 (47%) in women. Living at higher altitudes is associated with lower YYL per 100,000 people
(Table 3).
Table 3 Burden of stroke and years of life lost prematurely due to stroke in Ecuador from 2001-2017.
Altitude

Population

Deaths

Deaths per 1000
pop

YLL

(95% C.I.)
Low Altitude
Moderate
Altitude
High Altitude
Very High
Altitude
Total

8,941,296

3,543

1,424,273

537

4,360,711

1,249

252,194

84

14,978,474

5,413

0.40 (0.38 - 0.41)
0.38 (0.35 - 0.41)
0.29 (0.27 - 0.30)
0.33 (0.27 - 0.41)
0.36 (0.35 - 0.37)

YLL per 1000
pop.
(95% C.I.)

75,823

8.48 (8.42 8.54)

11,004

7.73 (7.58 7.87)

21,698

4.98 (4.91 5.04)

1,234

4.89 (4.62 5.17)

109,759

7.33 (7.28 7.37)

Discussion
Our study is the rst to describe the burden of stroke at four different elevation ranges. Ecuador is unique for this
type of analysis since it has populations residing from sea level to very high altitudes. Understanding the countrywide distribution of stroke in Ecuador has already important implications in terms of evaluating the burden of this
condition in a country where it has been poorly described before. Signi cant epidemiological differences in terms
of stroke incidence and mortality were found when compared to the population settled at lower altitudes. Our
results suggest that living at higher altitudes decreases the risk of stroke. The nationwide data from all the 221
elevations show that both men and women have fewer hospitalizations and lower incidence rates of stroke than
their low-altitude controls. Stroke-related deaths are also lower within the high-altitude group and the burden of
stroke measured in years of life lost (YLL) due to premature mortality is also lower at higher altitudes.
Our results suggest that living at higher altitudes decreases the risk of stroke due to the signi cant lower rates of
stroke admissions and mortality. Our results are similar to those reported in Switzerland in 2009, this was the only
publication similar to ours that longitudinally compare stroke mortality at high-altitude[22].
To date the burden of stroke has not been reported by altitude level. Our data suggest that living at higher altitudes
decreases the risk of stroke after adjusting for population, age, and sex.
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A possible explanation for the decreased risk of stroke in this population maybe due to physical activity, smoking
rates, incidence of obesity, and diet. These risk factors may play a role explaining the lower mortality and hospital
admission rates due to stroke among highlanders. Speci c data about risk factors could not be analysed due to
the lack of data in the national databases.
In terms of our ndings, we observed consistent dose-response relationship between high-altitude and a reduced
risk of developing stroke between 2,000 up to 3,500 meters of elevation. Beyond this point, other factors might be
involved in a reduction of this hypothesized protective effect. For instance, brain angiogenesis is a common
nding among acclimatized and adapted brain to high-altitude[27–29]. This is the postulated most important
protective factor when reducing the size of a stroke and when improving recovery after a ischemic episode at high
altitude[29–32]. Nevertheless, above this point, high haematocrit levels due to a signi cant polycythaemia causing
thicker blood overcome this protective factor, reducing blood ow, and causing statis as well as
thrombogenesis[33–36]. Although no data from human studies available our results support the plausible
relationship of a “protective window” that lays between 2,000 m to 3,500 m of elevation and anything below this
point progressively loses the hypostatized protective effect while anything above 3,500 confronts angiogenesis
and vascular remodelling versus high-altitude triggered thrombogenesis.
The data about risk factors available in Ecuador suggest that people living in provinces from the highlands
consume more alcohol (17.1% versus 9.1%) and smoke more (6.5% versus 2.5%) than the people living at lower
altitudes[37]. These behaviors might contradict the paradoxically lower mortality of stroke among highlanders[38]
People in the coast region seem to have higher consumption of carbohydrates (36 % versus 30%) and have inferior
access to health services (24 versus 32 health centres per every 100,000 people) than the persons in the
highlands[39]. In terms of diabetes, there is no published information about the differences for high and low
altitude population in Ecuador, nevertheless, the crude mortality rate according to the INEC database. We found
only one study that showed that diabetes in the coastal provinces is more prevalent (388 / 100,000) than in the
highlands (236,9 / 100,000), situation that is similar to other studies [40, 41]. Other risk factors such as
hypertension, obesity and sedentarism have been showed to be less prevalent among high-altitude dwellers
according to some of the available published data[42–44].
Although some of the risk factors are might be less prevalent among highlanders, other factors such as; higher
platelet adhesiveness, polycythaemia, hypoxemia may play a role increasing the risk of developing stroke in
altitudes beyond 3,500 m[18, 45–47].
Although a cause-effect relationship between high-altitude and stroke cannot be established with ecological
studies, our results suggest that milder chronic hypoxia could play a protective role for the development of stroke,
and more severe long-term hypoxia (>3,500 m) might be linked to a higher burden of cerebrovascular diseases[13,
22, 48, 49].

Limitations
The main limitation of this analysis is that some residual risk factors such as educational attainment, SES, BMI,
BP, smoking, diabetes and polycythaemia were not controlled since data is available. Observational
epidemiological studies, especially ecological ones, cannot conclude a cause-effect relationship, however, they are
very valuable for identifying associations and relationships for further investigations.
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Conclusions
This is the rst epidemiological study that explored the risk of developing stroke and the burden of cerebrovascular
disease at different elevations, ranging from 0 to 4,300 m above sea level. Our ndings suggest that living at
higher elevations offers a reduction or the risk of dying due to stroke as well as a reduction in the probability of
being admitted to the hospital. Nevertheless, this protective factor has the stronger effect between 2,000 m to
3,500 m and beyond this point, the hypostatised protective effect starts to compete against polycythaemia and
high viscosity blood, to well-known thrombogenic factors.
The results and the available literature suggest that high-altitude residents, probably due to their increased cerebral
microvasculature have better perfusion protecting the brain in some degree, against hypoxia. Although the results
of this ecological study support a previously proposed theory, more investigation is needed to understand the
complex relationship between hypobaric hypoxia, time of exposure and stroke.
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Figure 1
Overall age and sex-adjusted mortality rate by sex and elevation exposure
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Figure 2
Age-sex adjusted hospital rate due to stroke by age group in the low and high-altitude.
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Figure 3
Relative for mortality and hospital admissions in men and women living at 4 different elevation. Low altitude was
used as a reference variable.
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